These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1175133)

  • 1. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Aug; 14(8):865-9. PubMed ID: 700999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin's disease following treatment with hydantoins. Report of a case and review of the literature (author's transl)].
    Bladé Creixenti J; Segura Porta F; Nogué Xarau S; Soriano Marín E; García San Miguel J
    Med Clin (Barc); 1980 Jun; 75(1):24-6. PubMed ID: 7392707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 5. Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: report of a case and review of the literature.
    Sharma S; Menon H; Sengar M; Gujral S
    Indian J Pathol Microbiol; 2013; 56(4):440-2. PubMed ID: 24441243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].
    Pereira A; Cervantes F; Rozman C
    Med Clin (Barc); 1985 Oct; 85(12):503-5. PubMed ID: 4079508
    [No Abstract]   [Full Text] [Related]  

  • 7. Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns.
    Abbondazo SL; Irey NS; Frizzera G
    Am J Surg Pathol; 1995 Jun; 19(6):675-86. PubMed ID: 7755154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin sensitivity in a case of phenytoin-associated Hodgkin's disease.
    Sorrell TC; Forbes IJ
    Aust N Z J Med; 1975 Apr; 5(2):144-7. PubMed ID: 1057925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.
    Rubinstein I; Langevitz P; Shibi G
    Oncology; 1985; 42(2):104-6. PubMed ID: 3887259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).
    Lapes MJ; Vivacqua RJ; Antoniades K
    Lancet; 1976 Jan; 1(7952):198. PubMed ID: 54713
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy.
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Dec; 14(12):1265-7. PubMed ID: 748238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Lymphoma and anticonvulsive therapy.
    Tashima CK; De los Santos R
    JAMA; 1974 Apr; 228(3):287-8. PubMed ID: 4206090
    [No Abstract]   [Full Text] [Related]  

  • 14. Diphenylhydantoin (Dilantin) hypersensitivity.
    McGee FE; Singh R
    South Med J; 1970 Aug; 63(8):885 passim. PubMed ID: 4318354
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of a benign lymphoepithelial salivary gland lesion to lymphocytic lymphoma during dilantin therapy: correlation with dilantin-induced lymphocyte transformation in vitro.
    Lapes M; Antoniades K; Gartner W; Vivacqua R
    Cancer; 1976 Sep; 38(3):1318-22. PubMed ID: 989031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized pruritus as a presenting symptom of phenytoin-induced Hodgkin's disease.
    Rubinstein N; Weinrauch L; Matzner Y
    Int J Dermatol; 1985; 24(1):54-5. PubMed ID: 3997333
    [No Abstract]   [Full Text] [Related]  

  • 17. Casual or Causal? Two Unique Cases of Hodgkin's Lymphoma: A Case Report and Literature Review.
    Malik F; Ali N; Jafri SIM; Fidler C
    Am J Case Rep; 2017 May; 18():553-557. PubMed ID: 28522794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)].
    Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's disease in an epileptic treated with hydantoins].
    Guerin JM; Tibourtine O; Segrestaa JM; Nemeth J; Wassef M
    Presse Med; 1983 May; 12(23):1491. PubMed ID: 6222349
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.